Amgen (AMGN): FY25 Q3 earnings call, Nov 4, 2025
No Kalshi or Polymarket word markets were listed for Amgen’s Nov 4, 2025 earnings call (FY25 Q3). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
3 matches for “Tavneos”; 1 quoted, at least 25 words apart.
…a broad prescriber base who have indicated an increasing intent to prescribe. TAVNEOS sales were $107 million in the third quarter, an increase of 34%…
Agents: this page as TSV at /api/v1/appearances/amgen:2025-11-04:earnings_call · words: /api/v1/brief?appearance=amgen:2025-11-04:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP